-
Purposeexpression of MFGE8 in mammalian cells
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 46847 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepsd44iGFP
- Backbone size w/o insert (bp) 10500
-
Modifications to backboneIRES2 and EGFP was added to psd44 puro to make psd44-iGFP puro.
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameMFGE8
-
Alt namemilk fat globule-EGF factor 8 protein
-
Alt nameSED1
-
Alt namelactadherin
-
SpeciesM. musculus (mouse)
-
Insert Size (bp)1400
-
GenBank IDNM_008594
-
Entrez GeneMfge8 (a.k.a. MFG-E8, MP47, Mfgm, P47, SED1, lactadherin)
- Promoter PGK promoter
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XbaI (not destroyed)
- 3′ cloning site NheI (not destroyed)
- 5′ sequencing primer hPGK-F (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
derived from ImaGenes NM_008594_pcDNA3.1 (+). See http://www.lifesciences.sourcebioscience.com/genomecube.aspx?kw=MFGE8 for more info.
IRES2 and EGFP was added to psd44 puro to make psd44-iGFP puro.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
psd44-iGFP-MFGE8-long was a gift from Agnese Mariotti (Addgene plasmid # 46847 ; http://n2t.net/addgene:46847 ; RRID:Addgene_46847) -
For your References section:
MFG-E8/lactadherin regulates cyclins D1/D3 expression and enhances the tumorigenic potential of mammary epithelial cells. Carrascosa C, Obula RG, Missiaglia E, Lehr HA, Delorenzi M, Frattini M, Ruegg C, Mariotti A. Oncogene. 2012 Mar 22;31(12):1521-32. doi: 10.1038/onc.2011.356. Epub 2011 Aug 15. 10.1038/onc.2011.356 PubMed 21841820
Map uploaded by the depositor.